Literature DB >> 22253435

Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression.

Siddharth S Dey1, Yuhua Xue, Marcin P Joachimiak, Gregory D Friedland, John C Burnett, Qiang Zhou, Adam P Arkin, David V Schaffer.   

Abstract

Viral genomes are continually subjected to mutations, and functionally deleterious ones can be rescued by reversion or additional mutations that restore fitness. The error prone nature of HIV-1 replication has resulted in highly diverse viral sequences, and it is not clear how viral proteins such as Tat, which plays a critical role in viral gene expression and replication, retain their complex functions. Although several important amino acid positions in Tat are conserved, we hypothesized that it may also harbor functionally important residues that may not be individually conserved yet appear as correlated pairs, whose analysis could yield new mechanistic insights into Tat function and evolution. To identify such sites, we combined mutual information analysis and experimentation to identify coevolving positions and found that residues 35 and 39 are strongly correlated. Mutation of either residue of this pair into amino acids that appear in numerous viral isolates yields a defective virus; however, simultaneous introduction of both mutations into the heterologous Tat sequence restores gene expression close to wild-type Tat. Furthermore, in contrast to most coevolving protein residues that contribute to the same function, structural modeling and biochemical studies showed that these two residues contribute to two mechanistically distinct steps in gene expression: binding P-TEFb and promoting P-TEFb phosphorylation of the C-terminal domain in RNAPII. Moreover, Tat variants that mimic HIV-1 subtypes B or C at sites 35 and 39 have evolved orthogonal strengths of P-TEFb binding versus RNAPII phosphorylation, suggesting that subtypes have evolved alternate transcriptional strategies to achieve similar gene expression levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253435      PMCID: PMC3318752          DOI: 10.1074/jbc.M111.302653

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase.

Authors:  G Tachedjian; H E Aronson; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Dynamic association of capping enzymes with transcribing RNA polymerase II.

Authors:  S C Schroeder; B Schwer; S Shuman; D Bentley
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

3.  HIV-1 tat transcriptional activity is regulated by acetylation.

Authors:  R E Kiernan; C Vanhulle; L Schiltz; E Adam; H Xiao; F Maudoux; C Calomme; A Burny; Y Nakatani; K T Jeang; M Benkirane; C Van Lint
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

4.  Correlated mutations and residue contacts in proteins.

Authors:  U Göbel; C Sander; R Schneider; A Valencia
Journal:  Proteins       Date:  1994-04

5.  Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins.

Authors:  N Li; J Schlessinger; B Margolis
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

6.  Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.

Authors:  L Deng; C de la Fuente; P Fu; L Wang; R Donnelly; J D Wade; P Lambert; H Li; C G Lee; F Kashanchi
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

7.  Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.

Authors:  A Cimarelli; S Sandin; S Höglund; J Luban
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.

Authors:  M Zhou; M A Halanski; M F Radonovich; F Kashanchi; J Peng; D H Price; J N Brady
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  HIV promoter integration site primarily modulates transcriptional burst size rather than frequency.

Authors:  Ron Skupsky; John C Burnett; Jonathan E Foley; David V Schaffer; Adam P Arkin
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

10.  Association of Cdk-activating kinase subunits with transcription factor TFIIH.

Authors:  H Serizawa; T P Mäkelä; J W Conaway; R C Conaway; R A Weinberg; R A Young
Journal:  Nature       Date:  1995-03-16       Impact factor: 49.962

View more
  6 in total

1.  The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat.

Authors:  Shambhu Prasad G Aralaguppe; Shilpee Sharma; Malini Menon; Vinayaka R Prasad; Shanmugam Saravanan; Kailapuri G Murugavel; Suniti Solomon; Udaykumar Ranga
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02-09       Impact factor: 2.205

2.  tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.

Authors:  Raabya Rossenkhan; Iain J MacLeod; Theresa K Sebunya; Eduardo Castro-Nallar; Mary Fran McLane; Rosemary Musonda; Berhanu A Gashe; Vlad Novitsky; M Essex
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

3.  Impact of Tat Genetic Variation on HIV-1 Disease.

Authors:  Luna Li; Satinder Dahiya; Sandhya Kortagere; Benjamas Aiamkitsumrit; David Cunningham; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virol       Date:  2012-07-30

4.  Orthogonal control of expression mean and variance by epigenetic features at different genomic loci.

Authors:  Siddharth S Dey; Jonathan E Foley; Prajit Limsirichai; David V Schaffer; Adam P Arkin
Journal:  Mol Syst Biol       Date:  2015-05-05       Impact factor: 11.429

Review 5.  Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.

Authors:  Aurelio Cafaro; Antonella Tripiciano; Orietta Picconi; Cecilia Sgadari; Sonia Moretti; Stefano Buttò; Paolo Monini; Barbara Ensoli
Journal:  Vaccines (Basel)       Date:  2019-08-26

6.  Effect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern India.

Authors:  Sneh Lata; Larance Ronsard; Vikas Sood; Sajad A Dar; Vishnampettai G Ramachandran; Shukla Das; Akhil C Banerjea
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.